Five questions this week about a few common-and a few not so common-GI maladies. Test your clinical acumen...
QUESTION 1:
For the discussion, click here.
Click here for the next question.
For the answers, click here.
QUESTION 2:
For the discussion, click here.
Click here for the next question.
For the answers, click here.
Differentiating Crohn disease from ulcerative colitis can be difficult.
QUESTION 3:
For the discussion, click here.
Click here for the next question.
For the answers, click here.
QUESTION 4:
For the discussion, click here.
Click here for the next question.
For the answers, click here.
Direct evidence exists for the role of GI microbiota in the pathogenesis of inflammatory bowel disease, and there is some evidence that they play a similar role in irritable bowel syndrome.
QUESTION 5:
For the discussion, click here.
For the answers, click here.
A 55-year-old man presents with presyncope. His stools have been dark red and he has experienced mid-abdominal pain for a week. His abdomen is tender to palpation in the periumbilical region but is otherwise soft and without masses. His skin had circular areas of hyperpigmentation and multiple fleshy papules; that these had been present since childhood but the patient had never sought medical care.
ANSWER KEY:
Question 1. Answer: c
Question 2. Answer: c
Question 3. Answer: b
Question 4. Answer: d
Question 5. Answer: d
Clinical Tips for Using Antibiotics and Corticosteroids in IBD
January 5th 2013The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.